All Articles

A 209kg opium seizure reveals how Canada's billion-dollar investment in AI and intelligence is disrupting sophisticated global drug smuggling networks.

A Carroll, Ohio firm keeps winning top awards for managing wealth. We explore how its strategies are enabling affluent retirees to navigate uncertainty.

Designer Hiromi Asai redefines Japanese heritage at Miami Art Week, transforming sacred kimono textiles into sculptural menswear and making a bold market play.

A government crackdown on clergy and a top businessman raises serious questions about Armenia's judicial independence, spooking investors and allies alike.

As Virginia faces slowing growth, the business community presents a new decade-long economic plan to Governor-elect Spanberger. Can it deliver prosperity?

Ottawa's new protectionist policies for steel and lumber are more than a trade strategy; they're a massive public health intervention for at-risk communities.

Swedish innovator SciBase is overhauling its capital structure with a complex warrant buyback. Is this a strategic masterstroke or a necessary defensive play?

A Canadian firm's breakthrough promises to produce renewable natural gas at price parity with fossil fuels. Is this the key to unlocking a greener economy?

A smart appliance company is upending global expansion by proving that listening to local communities is the key to becoming a brand that truly matters.

USA Pickleball's exclusive DUPR deal aims to unify the sport, but a single rating system brings both professional legitimacy and player controversy.

A new national strategy combines massive insurance expansion with targeted educational funding to fix Canada’s oral health crisis and ease ER pressure.

A seizure of fake Viagra at a Toronto convenience store reveals the dangerous shadow economy of counterfeit drugs threatening public health and business integrity.

Following a strategic merger, the National Down Syndrome Society appoints six new leaders, signaling a new era of inclusive, research-driven advocacy.

Up to 60% of disability claims are denied, leaving sick Canadians in financial ruin. We explore the insurer tactics and the fight to reclaim benefits.

Empire State Realty Trust's latest dividend signals resilience. We explore how its modernized portfolio and NYC's market rebound create stability.

Boston-based 1910 Genetics unveils an AI model that bypasses decades-old barriers, opening a vast new frontier for treating Alzheimer's and Parkinson's.

The global caterer's share repurchase signals more than financial health; it's a strategic move to fuel growth, reward investors, and reshape its future.

Healthcare tech firm StaffDNA’s title sponsorship of the Cure Bowl is more than a game—it's a calculated move blending branding with a cancer research mission.

In a powerful move, Ashkenazy Acquisition Corp. acquires a major Chicago retail center, part of a $750M spree that defies market doomsayers.

The Dot Corp's new division signals a major shift in marketing logistics. Why are companies abandoning siloed vendors for a single source of truth?